University of Oxford — Improved first-generation Malaria Vaccine Development

Organization:
Global Health R&D
Award Date:
12/2024
Amount:
$4,296,130
Purpose:
To support the development of an improved first-generation malaria vaccine (R21/Rh5/R78C).